Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.
Published By Datamonitor
|
25 Apr 2013 |
$3500
|
Report
|
Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market
Published By Datamonitor
|
24 Apr 2013 |
$2500
|
Report
|
The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.
Published By Datamonitor
|
17 Apr 2013 |
$4500
|
Brief
|
NHS reform is impacting pharmaceutical companies’ interaction with key stakeholders.
Published By Datamonitor
|
25 Mar 2013 |
$500
|
Report
|
Trends in gene vector technologies and insight into their application in various therapy areas.
Published By Datamonitor
|
25 Mar 2013 |
$3500
|
Report
|
The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.
Published By Datamonitor
|
22 Mar 2013 |
$4500
|
Report
|
Indonesia is the world’s fourth most populous country with a population of approximately 240 million. This, in addition to a rapidly growing economy presents a huge opportunity for the pharmaceutical industry.
Published By Datamonitor
|
11 Mar 2013 |
$2500
|
Report
|
Branded generics produced by foreign companies continue to dominate the market.
Published By Datamonitor
|
01 Mar 2013 |
$1900
|
Report
|
Commoditization in the CMO market is driving the leading players to niche services
Published By Datamonitor
|
22 Feb 2013 |
$3500
|
Report
|
The biologic drug market is growing at nearly twice the pace of the overall pharma market. This report forecasts microbial and mammalian contract manufacturing markets to 2017. Market dynamics and leading players are also examined.
Published By Datamonitor
|
19 Feb 2013 |
$3500
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.